Hawkins (NASDAQ:HWKN – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at BWS Financial in a note issued to investors on Tuesday, Benzinga reports. They presently have a $200.00 price objective on the specialty chemicals company’s stock. BWS Financial‘s price objective points to a potential upside of 30.00% from the company’s current price.
Several other equities analysts have also commented on HWKN. Weiss Ratings raised shares of Hawkins from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, September 21st. Barclays set a $141.00 price target on shares of Hawkins and gave the company an “equal weight” rating in a research note on Tuesday, October 13th. Finally, Zacks Research downgraded shares of Hawkins from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 4th. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $170.50.
View Our Latest Stock Analysis on HWKN
Hawkins Price Performance
HWKN stock traded up $18.41 during mid-day trading on Tuesday, hitting $153.85. The stock had a trading volume of 423,840 shares, compared to its average volume of 164,109. The company has a current ratio of 2.27, a quick ratio of 1.54 and a debt-to-equity ratio of 0.45. Hawkins has a 52 week low of $116.04 and a 52 week high of $174.12. The firm has a market capitalization of $3.21 billion, a P/E ratio of 39.86, a P/E/G ratio of 2.71 and a beta of 0.74. The firm has a fifty day simple moving average of $126.44 and a 200 day simple moving average of $143.14.
Hawkins (NASDAQ:HWKN – Get Free Report) last released its earnings results on Monday, October 26th. The specialty chemicals company reported $1.34 EPS for the quarter, beating the consensus estimate of $1.19 by $0.15. Hawkins had a net margin of 7.29% and a return on equity of 15.42%. The firm had revenue of $313.82 million for the quarter, compared to analyst estimates of $302.70 million. As a group, research analysts forecast that Hawkins will post 4.07 EPS for the current year.
Insider Buying and Selling
In related news, CFO Jeffrey Oldenkamp purchased 1,290 shares of Hawkins stock in a transaction dated Thursday, August 27th. The shares were bought at an average cost of $119.00 per share, for a total transaction of $153,510.00. Following the purchase, the chief financial officer owned 104,223 shares in the company, valued at approximately $12,402,537. This trade represents a 1.25% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Douglas Lange bought 910 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The shares were acquired at an average price of $118.75 per share, for a total transaction of $108,062.50. Following the completion of the transaction, the vice president owned 28,169 shares in the company, valued at $3,345,068.75. This trade represents a 3.34% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 3.70% of the company’s stock.
Institutional Investors Weigh In On Hawkins
Several hedge funds have recently added to or reduced their stakes in HWKN. BlackRock Inc. acquired a new stake in Hawkins during the 2nd quarter worth approximately $449,055,000. William Blair Investment Management LLC acquired a new stake in Hawkins during the 2nd quarter worth approximately $27,212,000. London Co. of Virginia acquired a new stake in Hawkins during the 1st quarter worth approximately $26,791,000. Bank of New York Mellon Corp acquired a new stake in Hawkins during the 2nd quarter worth approximately $20,071,000. Finally, Giverny Capital Inc. acquired a new stake in Hawkins during the 2nd quarter worth approximately $13,493,000. 69.71% of the stock is currently owned by institutional investors and hedge funds.
Key Hawkins News
Here are the key news stories impacting Hawkins this week:
- Positive Sentiment: Strong earnings and revenue beat: Fiscal Q2 revenue reached $313.8 million, up 11.9% year over year and above the approximately $302.7 million analyst estimate. Adjusted earnings of $1.34 per share exceeded consensus estimates ranging from $1.19 to $1.22 and increased from $1.08 a year earlier. Hawkins fiscal Q2 results
- Positive Sentiment: Improved profitability and cash generation: Gross profit rose to $76.6 million, operating profit reached $41.9 million, and net income attributable to common shareholders increased to $27.8 million. Operating cash flow was $40.3 million, while total liabilities declined, supporting the view that the earnings growth was accompanied by solid financial quality. Hawkins Q2 earnings analysis
- Positive Sentiment: Dividend increased: Hawkins declared a quarterly dividend of $0.20 per share, payable November 25 to shareholders of record November 11. The payment represents a 5.3% increase from $0.19 and an annualized dividend of $0.80, signaling continued confidence in cash flows. Hawkins dividend announcement
- Neutral Sentiment: Investor takeaway: The results triggered a sharp post-earnings rally, with trading volume above average. However, Hawkins trades at a relatively elevated valuation—approximately 40 times earnings—so continued share-price gains may depend on sustaining its earnings and margin momentum.
Hawkins Company Profile
Hawkins, Inc (NASDAQ:HWKN) is a chemical manufacturer, blender and distributor serving customers across the United States. The company supplies a range of water treatment chemicals, industrial chemicals and specialty products to municipal, commercial and industrial users.
Its water treatment business provides chemicals and related solutions used in drinking water, wastewater and industrial water treatment applications. Hawkins also serves the industrial, health and nutrition, and specialty chemical markets, offering products such as chemical blends, custom formulations and other materials used in manufacturing, agriculture, food processing and pharmaceutical applications.
Founded in 1938, Hawkins is headquartered in Roseville, Minnesota, and operates through a network of manufacturing, blending, distribution and sales locations in the United States.
Featured Stories
- Five stocks we like better than Hawkins
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
